ResMed (NYSE:RMD), a leader in sleep apnea and respiratory care solutions, reported strong fiscal 2025 second-quarter earnings on Thursday, Jan. 30. The medical device company outperformed analyst ...

(RTTNews) - Resmed Inc (RMD) revealed a profit for its second quarter that increased from last year and beat the Street estimates. The company's earnings totaled $344.6 million, or $2.34 per share.

CSL Ltd (ASX: CSL) and ResMed Inc (ASX: RMD) shares are popular blue chip options for investors. But are they in the buy zone right now? Let's take a look at what one leading broker is saying ...

ResMed’s (ASX:RMD) half-year FY25 results reflect a company that is not only thriving in its core business but is also strategically positioned to capitalise on future growth opportunities. The ...

Sleep and respiratory disorders sector of the medical device industry ("Sleep and Respiratory Care') and the supply of business management software as a service to out-of-hospital health providers ...

Related reads:PC vs SEC: Check our Fantasy Cricket Prediction, Tips, Playing Team Picks for SA20 2025, Match 7 on January 14th In the derby clash, Melbourne Renegades will take on Melbourne Stars ...

There’s an old proverb from Roman poet Quintus Ennius: a friend in need, is a friend indeed. Then there’s Vince Vaughn’s line from The Wedding Crashers: “A friend in need is a pest.” The ...

The stock market this Friday has witnessed notable fluctuations with certain stocks experiencing significant movements. In the mega-cap and large-cap categories, companies like AbbVie Inc (NYSE:ABBV) ...